Syntegra partners with TMA Precision to reduce the diagnostic odyssey for rare disease with synthetic data-enabled tools
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Subscribe To Our Newsletter & Stay Updated